Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients. Horimoto Y, Ishizuka Y, Ueki Y, Higuchi T, et al. BMC Cancer 2022;22:242.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Horimoto Y, Ishizuka Y, Ueki Y, Higuchi T, et al. Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients. BMC Cancer 2022;22:242.
PMID: 35248011